Know Cancer

or
forgot password

Total Xonoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Risk


Phase 4
55 Years
70 Years
Open (Enrolling)
Female
Breast Cancer Risk

Thank you

Trial Information

Total Xonoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Risk


Inclusion Criteria:



- 55-70 years of age, Post menopausal

Exclusion Criteria:

- If they have ever used hormone replacment therapy or have ever used Tamoxifen or
Raloxifene, Diag. with breast cancer have had breast implants or have had a
mastectomy/

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Characterize the distribution of total xenoestrogen burden and identify important source of xenoestrogen exposure among a clinic-based sample of postmenopausal women.

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Amy Trentham Dietz, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Associate Professor- Population Health Sciences, UW School of Medicine and Public Health

Authority:

United States: Institutional Review Board

Study ID:

CC07104

NCT ID:

NCT00839696

Start Date:

July 2008

Completion Date:

February 2012

Related Keywords:

  • Breast Cancer Risk
  • Breast
  • Estrogens
  • Mammography
  • Breast Neoplasms

Name

Location
University of Wisconsin Hospital Madison, Wisconsin  53792